{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T13:51:19Z","timestamp":1783000279517,"version":"3.54.5"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Science and Technology Research Project of Henan Province, China","award":["162102310540"],"award-info":[{"award-number":["162102310540"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.lfs.2020.118689","type":"journal-article","created":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T19:00:10Z","timestamp":1603998010000},"page":"118689","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Hepatoprotective effect of gentiopicroside in combination with leflunomide and\/or methotrexate in arthritic rats"],"prefix":"10.1016","volume":"265","author":[{"given":"Zhijie","family":"Wan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2020.118689_bb0005","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2018.1","article-title":"Rheumatoid arthritis","volume":"4","author":"Smolen","year":"2018","journal-title":"Nature Reviews. Disease Primers"},{"key":"10.1016\/j.lfs.2020.118689_bb0010","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.0105-2896.2009.00859.x","article-title":"Fibroblast like synoviocytes: key effector cells in rheumatoid arthritis","volume":"233","author":"Bartok","year":"2010","journal-title":"Immunol. Rev."},{"issue":"3","key":"10.1016\/j.lfs.2020.118689_bb0015","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/art.1780170317","article-title":"Relation of cellular infiltration of rheumatoid synovial membrane to its immune response","volume":"17","author":"Ziff","year":"1974","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.lfs.2020.118689_bb0020","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.3389\/fimmu.2019.01384","article-title":"The rheumatoid arthritis risk gene AIRE is induced by cytokines in fibroblast-like Synoviocytes and augments the pro-inflammatory response","volume":"10","author":"Bergstrom","year":"2019","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.lfs.2020.118689_bb0025","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.rdc.2010.02.004","article-title":"Cell-cell interactions in rheumatoid arthritis synovium","volume":"36","author":"Fox","year":"2010","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"10.1016\/j.lfs.2020.118689_bb0030","article-title":"Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying antirheumatic drugs for rheumatoid arthritis: abridged Cochrane systematic review and network meta-analysis","volume":"353","author":"Hazlewood","year":"2016","journal-title":"Bmj"},{"key":"10.1016\/j.lfs.2020.118689_bb0035","first-page":"1","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update","volume":"0","author":"S.","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.lfs.2020.118689_bb0040","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1080\/14397595.2017.1414765","article-title":"Risk factors for abnormal hepatic enzyme elevation by methotrexate treatment in patients with rheumatoid arthritis: a hospital based-cohort study","volume":"28","author":"Hakamata","year":"2018","journal-title":"Mod. Rheumatol."},{"issue":"3","key":"10.1016\/j.lfs.2020.118689_bb0045","first-page":"197","article-title":"Hepatotoxicity of methotrexate in rheumatic diseases","volume":"3","author":"S","year":"1988","journal-title":"Med Toxicol Adverse Drug Exp"},{"issue":"1","key":"10.1016\/j.lfs.2020.118689_bb0050","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nut.2015.06.010","article-title":"Omega-3 fatty acids as an adjuvant therapy ameliorates methotrexate-induced hepatotoxicity in children and adolescents with acute lymphoblastic leukemia: a randomized placebo-controlled study","volume":"32","author":"Elbarbary","year":"2016","journal-title":"Nutrition"},{"issue":"7","key":"10.1016\/j.lfs.2020.118689_bb0055","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s10067-017-3687-5","article-title":"Clinical effectiveness and safety of leflunomide in inflammatory arthritis: a report from the RAPPORT database with supporting patient survey","volume":"36","author":"Schultz","year":"2017","journal-title":"Clin. Rheumatol."},{"issue":"5","key":"10.1016\/j.lfs.2020.118689_bb0060","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1177\/1759720X16664324","article-title":"Combination leflunomide and methotrexate in refractory rheumatoid arthritis: a biologic sparing approach","volume":"8","author":"Hodkinson","year":"2016","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"1","key":"10.1016\/j.lfs.2020.118689_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/acr.22783","article-title":"American college of, 2015 American College of Rheumatology Guideline for the treatment of rheumatoid arthritis","volume":"68","author":"Singh","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"10.1016\/j.lfs.2020.118689_bb0070","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1136\/ard.2005.043620","article-title":"Leflunomide and methotrexate combination therapy in daily clinical practice","volume":"65","author":"Dendooven","year":"2006","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.lfs.2020.118689_bb0075","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1124\/mol.117.110593","article-title":"Leflunomide increases hepatic exposure to methotrexate and its metabolite by differentially regulating multidrug resistance-associated protein Mrp2\/3\/4 transporters via peroxisome proliferator-activated receptor alpha activation","volume":"93","author":"Wang","year":"2018","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.lfs.2020.118689_bb0080","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4103\/jpp.JPP_93_16","article-title":"Severe bone marrow suppression accompanying pulmonary infection and hemorrhage of the digestive tract associated with leflunomide and low-dose methotrexate combination therapy","volume":"8","author":"Qu","year":"2017","journal-title":"J. Pharmacol. Pharmacother."},{"issue":"1","key":"10.1016\/j.lfs.2020.118689_bb0085","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.pharep.2014.08.009","article-title":"Myelosuppressive and hepatotoxic potential of leflunomide and methotrexate combination in a rat model of rheumatoid arthritis","volume":"67","author":"Bilasy","year":"2015","journal-title":"Pharmacol. Rep."},{"issue":"1","key":"10.1016\/j.lfs.2020.118689_bb0090","doi-asserted-by":"crossref","first-page":"E48","DOI":"10.1208\/aapsj080106","article-title":"Mechanisms of drug-induced liver injury","volume":"8","author":"Holt","year":"2006","journal-title":"AAPS J."},{"issue":"47","key":"10.1016\/j.lfs.2020.118689_bb0095","doi-asserted-by":"crossref","first-page":"5297","DOI":"10.3748\/wjg.v24.i47.5297","article-title":"Hepatitis C: from inflammatory pathogenesis to anti-inflammatory\/hepatoprotective therapy","volume":"24","author":"Li","year":"2018","journal-title":"World J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.lfs.2020.118689_bb0100","doi-asserted-by":"crossref","first-page":"488","DOI":"10.4103\/1735-5362.272535","article-title":"Hepatoprotective potential and antioxidant activity of Allium tripedale in acetaminophen-induced oxidative damage","volume":"14","author":"Ghobadi","year":"2019","journal-title":"Research in Pharmaceutical Sciences"},{"issue":"1","key":"10.1016\/j.lfs.2020.118689_bb0105","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3109\/03602532.2011.602688","article-title":"Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: lessons learned from acetaminophen hepatotoxicity","volume":"44","author":"Jaeschke","year":"2012","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.lfs.2020.118689_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105754","article-title":"The role of inflammasome activation in Triptolide-induced acute liver toxicity","volume":"75","author":"Yuan","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.lfs.2020.118689_bb0115","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.toxlet.2018.04.021","article-title":"IL-17 deficiency attenuates acetaminophen-induced hepatotoxicity in mice","volume":"292","author":"Lee","year":"2018","journal-title":"Toxicol. Lett."},{"issue":"6","key":"10.1016\/j.lfs.2020.118689_bb0120","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/abbs\/gmx040","article-title":"CXCL16 deficiency attenuates acetaminophen-induced hepatotoxicity through decreasing hepatic oxidative stress and inflammation in mice","volume":"49","author":"Wang","year":"2017","journal-title":"Acta Biochim. Biophys. Sin. Shanghai"},{"issue":"4","key":"10.1016\/j.lfs.2020.118689_bb0125","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1016\/j.bbrc.2017.12.112","article-title":"Gentiopicroside ameliorates bleomycin-induced pulmonary fibrosis in mice via inhibiting inflammatory and fibrotic process","volume":"495","author":"Chen","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.lfs.2020.118689_bb0130","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.arcmed.2018.10.005","article-title":"Geniposide and gentiopicroside suppress hepatic gluconeogenesis via regulation of AKT-FOXO1 pathway","volume":"49","author":"Yang","year":"2018","journal-title":"Arch. Med. Res."},{"issue":"4","key":"10.1016\/j.lfs.2020.118689_bb0135","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2133\/dmpk.DMPK-12-RG-090","article-title":"In vitro inhibition and induction of human liver cytochrome P450 enzymes by gentiopicroside: potent effect on CYP2A6","volume":"28","author":"Deng","year":"2013","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.lfs.2020.118689_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105840","article-title":"Therapeutic effects of gentiopicroside on adjuvant-induced arthritis by inhibiting inflammation and oxidative stress in rats","volume":"76","author":"Xie","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.lfs.2020.118689_bb0145","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.intimp.2017.11.007","article-title":"Activation of Nrf2 pathway and inhibition of NLRP3 inflammasome activation contribute to the protective effect of chlorogenic acid on acute liver injury","volume":"54","author":"Shi","year":"2018","journal-title":"Int. Immunopharmacol."},{"issue":"5","key":"10.1016\/j.lfs.2020.118689_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25051219","article-title":"Investigation of a medical plant for hepatic diseases with secoiridoids using HPLC and FT-IR spectroscopy for a case of Gentiana rigescens","volume":"25","author":"Yang","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.lfs.2020.118689_bb0155","doi-asserted-by":"crossref","first-page":"116750","DOI":"10.1016\/j.lfs.2019.116750","article-title":"Anti-arthritic effect of beta-caryophyllene and its ameliorative role on methotrexate and\/or leflunomide-induced side effects in arthritic rats","volume":"233","author":"El-Sheikh","year":"2019","journal-title":"Life Sci."},{"issue":"1\u20133","key":"10.1016\/j.lfs.2020.118689_bb0160","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ejphar.2012.10.024","article-title":"Evaluation of the effect of losartan and methotrexate combined therapy in adjuvant-induced arthritis in rats","volume":"698","author":"Refaat","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2020.118689_bb0165","first-page":"5394","article-title":"Acute renal injury induced by endotoxic shock in rats is alleviated via PI3K Nrf2 pathway","volume":"22","author":"H.C.","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.lfs.2020.118689_bb0170","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jhep.2007.07.006","article-title":"Grading and staging systems for inflammation and fibrosis in chronic liver diseases","volume":"47","author":"Goodman","year":"2007","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2020.118689_bb0175","doi-asserted-by":"crossref","first-page":"S331","DOI":"10.1016\/S1590-8658(11)60589-6","article-title":"Chronic viral hepatitis: the histology report","volume":"43","author":"Guido","year":"2011","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.lfs.2020.118689_bb0180","doi-asserted-by":"crossref","unstructured":"M. Sellami, O. Saidane, I. Mahmoud, A.B. Tekaya, R. Tekaya, L. Abdelmoula, Etiological features of liver involvement in rheumatoid arthritis, Curr. Rheumatol. Rev. Oct 7(1875\u20136360 (Electronic)) doi: https:\/\/doi.org\/10.2174\/1573397115666191007121605.","DOI":"10.2174\/1573397115666191007121605"},{"key":"10.1016\/j.lfs.2020.118689_bb0185","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.biopha.2018.07.001","article-title":"Evaluation of the effect of andrographolide and methotrexate combined therapy in complete Freund\u2019s adjuvant induced arthritis with reduced hepatotoxicity","volume":"106","author":"Li","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.lfs.2020.118689_bb0190","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/0471141755.ph0504s70","article-title":"Models of inflammation: carrageenan- or complete Freund\u2019s adjuvant (CFA)\u2013induced edema and hypersensitivity in the rat","volume":"70","author":"McCarson","year":"2015","journal-title":"Curr Protoc Pharmacol"},{"issue":"3","key":"10.1016\/j.lfs.2020.118689_bb0195","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.reuma.2017.07.020","article-title":"Systematic review and meta-analysis of the efficacy and safety of leflunomide and methotrexate in the treatment of rheumatoid arthritis","volume":"15","author":"Alfaro-Lara","year":"2019","journal-title":"Reumatol Clin"},{"issue":"12","key":"10.1016\/j.lfs.2020.118689_bb0200","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.2165\/11316650-000000000-00000","article-title":"Benefit-risk assessment of leflunomide:an appraisal of leflunomide in rheumatoid arthritis 10 years after licensing","volume":"32","author":"Nicola","year":"2009","journal-title":"Drug Saf."},{"key":"10.1016\/j.lfs.2020.118689_bb0205","doi-asserted-by":"crossref","first-page":"7891574","DOI":"10.1155\/2016\/7891574","article-title":"Oxidative stress and liver cancer: etiology and therapeutic targets","volume":"2016","author":"Wang","year":"2016","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"25","key":"10.1016\/j.lfs.2020.118689_bb0210","doi-asserted-by":"crossref","first-page":"8082","DOI":"10.3748\/wjg.v20.i25.8082","article-title":"Oxidative stress as a crucial factor in liver diseases","volume":"20","author":"Cicho\u017c-Lach","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.lfs.2020.118689_bb0215","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3453926","article-title":"Naturally occurring Nrf2 activators: potential in treatment of liver injury","volume":"2016","author":"Jadeja","year":"2016","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.lfs.2020.118689_bb0220","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/763257","article-title":"Role of the Nrf2-ARE pathway in liver diseases","volume":"2013","author":"Shin","year":"2013","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"2","key":"10.1016\/j.lfs.2020.118689_bb0225","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/toxsci\/kfq009","article-title":"Mechanisms of immune-mediated liver injury","volume":"115","author":"Adams","year":"2010","journal-title":"Toxicol. Sci."},{"issue":"2","key":"10.1016\/j.lfs.2020.118689_bb0230","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jhep.2014.04.012","article-title":"Human serum albumin, systemic inflammation, and cirrhosis","volume":"61","author":"Arroyo","year":"2014","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.lfs.2020.118689_bb0235","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/hep.28740","article-title":"Systemic inflammation in decompensated cirrhosis: characterization and role in acute-on-chronic liver failure","volume":"64","author":"Claria","year":"2016","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.lfs.2020.118689_bb0240","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000488690","article-title":"Immunodysfunction in acute-on-chronic liver failure","volume":"34","author":"Lange","year":"2018","journal-title":"Visc Med"},{"issue":"8","key":"10.1016\/j.lfs.2020.118689_bb0245","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11081053","article-title":"Context-dependent role of NF-kappaB signaling in primary liver cancer-from tumor development to therapeutic implications","volume":"11","author":"Czauderna","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.lfs.2020.118689_bb0250","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrgastro.2010.213","article-title":"NF-kappaB in the liver\u2013linking injury, fibrosis and hepatocellular carcinoma","volume":"8","author":"Luedde","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.lfs.2020.118689_bb0255","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cbpc.2018.10.002","article-title":"Antioxidative, anti-inflammatory and hepatoprotective effects of resveratrol on oxidative stress-induced liver damage in tilapia (Oreochromis niloticus)","volume":"215","author":"Jia","year":"2019","journal-title":"Comp Biochem Physiol C Toxicol Pharmacol"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520314429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520314429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:40:39Z","timestamp":1758400839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320520314429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":51,"alternative-id":["S0024320520314429"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118689","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatoprotective effect of gentiopicroside in combination with leflunomide and\/or methotrexate in arthritic rats","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118689","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"118689"}}